Comparative Benchmarking
In the context of the broader market, ADAG competes directly with industry leaders such as VRCA and ABOS. With a market capitalization of $131.02M, it holds a significant position in the sector. When comparing efficiency, ADAG's gross margin of N/A stands against VRCA's 92.27% and ABOS's N/A. Such benchmarking helps identify whether Adagene Inc is trading at a premium or discount relative to its financial performance.